Valneva Seeks Covid Vaccine Approval On AstraZeneca Head-To-Head Data Alone
UK Is Pioneering ‘Correlates Of Protection’ Study
The partnership between Valneva and the UK government could produce the first COVID vaccine approval based on immunogenicity data.
You may also be interested in...
The European Commission has approved a purchase deal for Valneva’s COVID-19 vaccine candidate just months after the UK scrapped its own deal with the firm.
Following positive interim Phase I/II results, expectations are rising for SK Bioscience’s recombinant COVID-19 vaccine as it becomes the first Korea-developed candidate to progress to Phase III.
In this week's podcast edition of Five Must-Know Things: a ground-breaking approval for Alzheimer’s in the US; LAG-3 inhibitors and new Keytruda data generate excitement at ASCO; and clinical progress for another COVID-19 vaccine.